---
schema_version: "secwatch.filing_event.v1"
accession: "0001575872-25-000240"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T02:12:05.130973+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed closes $6.56M IPO of 1.64M shares at $4.00; Nasdaq ADVB

## Summary
- Priced 1,640,000 shares at $4.00/share for gross proceeds of $6.56 million.
- Underwriter granted 45-day option to purchase up to 246,000 additional shares.
- Representative's warrants to purchase 98,400 shares at $5.00/share.
- Proceeds to fund IVD clinical research, chip development, marketing, and working capital.
- Shares commenced trading on Nasdaq Capital Market on March 6, 2025 under ticker ADVB.

## SEC filing metadata
- accession: 0001575872-25-000240
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000157587225000240/0001575872-25-000240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000157587225000240/advb-20250307.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001575872-25-000240
- JSON: https://secwatch.observer/filing/0001575872-25-000240.json
- Plain text: https://secwatch.observer/filing/0001575872-25-000240.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.